Federal Circuit orders stay of PTAB’s Restasis proceedings

The US Court of Appeals for the Federal Circuit has ordered the Patent and Trial Appeal Board (PTAB) to halt its review of patents covering a dry eye medication while the court considers arguments that tribal immunity protects the patents from board proceedings.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Allergan and tribe to appeal PTAB’s immunity decision

2 March 2018 The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity.

Americas

Tribal immunity not applicable in IPR, says Fed Circuit

20 July 2018 Allergan and the Saint Regis Mohawk Tribe suffered a blow today as the US Court of Appeals for the Federal Circuit affirmed a decision rejecting use of tribal sovereign immunity in the inter partes review.

Americas

Allergan-tribe ruling raises questions over immunity at PTAB: lawyers

24 July 2018 The US Court of Appeals for the Federal Circuit’s ruling that tribal sovereign immunity doesn’t apply in inter partes review proceedings has sparked questions over state protections at the Patent Trial and Appeal Board.

More on this story

Americas

Allergan and tribe to appeal PTAB’s immunity decision

2 March 2018 The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity.

Americas

Tribal immunity not applicable in IPR, says Fed Circuit

Americas

Allergan-tribe ruling raises questions over immunity at PTAB: lawyers

More on this story

Americas

Allergan and tribe to appeal PTAB’s immunity decision

2 March 2018 The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity.

Americas

Tribal immunity not applicable in IPR, says Fed Circuit

Americas

Allergan-tribe ruling raises questions over immunity at PTAB: lawyers